Breaking News Instant updates and real-time market news.

MDT

Medtronic

$80.58

-0.35 (-0.43%)

06:52
11/22/16
11/22
06:52
11/22/16
06:52

Medtronic CEO says Q2 challenges 'could persist near term'

While some of the challenges that affected revenue in Q2 could persist in the near term, we remain confident in our ability to deliver mid-single digit constant currency revenue growth and double-digit constant currency EPS growth, not only in our current fiscal year, but on a sustained basis into the future," said CEO Ishrak. "As always, we remain committed to applying our medical technology and solutions to help address the universal healthcare needs of improving clinical outcomes, expanding access to care, and optimizing cost and efficiency, which combined represent a perpetual source of opportunity in healthcare."

  • 22

    Nov

MDT Medtronic
$80.58

-0.35 (-0.43%)

11/02/16
BMOC
11/02/16
NO CHANGE
BMOC
Dexcom still has positive catalysts, says BMO Capital
After Dexcom reported higher than expected Q3 revenue but said it does not expect its 2016 revenue to come in above its previous guidance range, BMO Capital analyst Joanne Wuensch says that the company's Q4 and 2017 results will probably be negatively impacted by Medtronic's (MDT) upcoming MiniMed 670G product. Nonetheless, the analyst says that the pending non-adjunctive label for Dexcom's CGM "can make waves," while it has "ample" room for growth in its "vastly underserved" market, as its "technology is nowhere near its full potential." The analyst cut her price target on the shares to $90 from $112 but keeps an Outperform rating on the stock.
11/14/16
EVER
11/14/16
NO CHANGE
EVER
Medtronic, Edwards Lifesciences defended at Evercore ISI
11/14/16
PIPR
11/14/16
NO CHANGE
PIPR
Overweight
Piper would buy TAVR names on 'GARY' registry weakness
Piper Jaffray analyst Brooks West attributes today's weakness in transcatheter aortic valve replacement makers Medtronic (MDT), Edwards Lifesciences (EW) and Boston Scientific (BSX) to a presentation at the AHA meeting of data from the German Aortic Valve Registry, or "GARY," comparing one year outcomes for patients at intermediate surgical risk who underwent isolated interventional versus conventional surgical aortic valve replacement for severe symptomatic aortic valve stenosis. The data showed a surprisingly negative result, but prior debates around the "GARY" led to no impact on TAVR volumes and West is "skeptical of the results," he tells investors. The firm has Overweight ratings on all three stocks mentioned above.
11/15/16
LEER
11/15/16
NO CHANGE
LEER
Edwards Lifesciences, Medtronic selloff overdone, says Leerink
Leerink analyst Danielle Antalffy notes that both Edwards Lifesciences (EW) and Medtronic (MDT) traded down in reaction to a presentation of the German Aortic Valve Registry data in intermediate risk patients. However, she believes the selloff is overdone, with no change to her estimated total addressable transcatheter aortic valve replacement, or TAVR, market opportunity as there are key baseline characteristic differences between both the surgical valve and TAVR groups that skews the data, and randomized controlled clinical trial data trumps registry data.

TODAY'S FREE FLY STORIES

LPL

LG Display

$15.59

1.33 (9.33%)

16:38
01/23/18
01/23
16:38
01/23/18
16:38
Upgrade
LG Display rating change  »

LG Display upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GDS

GDS Holdings

$26.75

-0.22 (-0.82%)

16:37
01/23/18
01/23
16:37
01/23/18
16:37
Syndicate
Breaking Syndicate news story on GDS Holdings »

GDS Holdings files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:36
01/23/18
01/23
16:36
01/23/18
16:36
General news
API crude inventories for week of January 19 »

API reports that crude…

NAVI

Navient

$13.44

-0.08 (-0.59%)

16:34
01/23/18
01/23
16:34
01/23/18
16:34
Earnings
Breaking Earnings news story on Navient »

Navient reports Q4 GAAP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

FHN

First Horizon

$20.11

0.01 (0.05%)

16:34
01/23/18
01/23
16:34
01/23/18
16:34
Hot Stocks
First Horizon replaces share repurchase program »

The board of First…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FHN

First Horizon

$20.11

0.01 (0.05%)

16:33
01/23/18
01/23
16:33
01/23/18
16:33
Hot Stocks
First Horizon increases quarterly dividend 33% »

First Horizon National…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SD

SandRidge Energy

$19.29

-0.02 (-0.10%)

16:32
01/23/18
01/23
16:32
01/23/18
16:32
Hot Stocks
SandRidge Energy: Not in best interests of holders to accept Ichan's proposal »

SandRidge Energy issued a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CQP

Cheniere Energy Partners

$31.30

0.41 (1.33%)

16:32
01/23/18
01/23
16:32
01/23/18
16:32
Hot Stocks
Cheniere Energy Partners raises dividend to 50c from 44c »

Cheniere Energy Partners,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

GORO

Gold Resource

$4.97

0.05 (1.02%)

16:32
01/23/18
01/23
16:32
01/23/18
16:32
Hot Stocks
Gold Resource to expand Arista Mine vein system »

Gold Resource announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

TRMK

Trustmark

$33.53

-0.03 (-0.09%)

16:31
01/23/18
01/23
16:31
01/23/18
16:31
Earnings
Trustmark reports Q4 adjusted EPS 48c, consensus 47c »

Gerard R. Host, President…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

16:30
01/23/18
01/23
16:30
01/23/18
16:30
Options
Preliminary option volume of 22.5M today »

Preliminary option volume…

SBBP

Strongbridge Biopharma

$8.70

0.25 (2.96%)

16:27
01/23/18
01/23
16:27
01/23/18
16:27
Syndicate
Strongbridge Biopharma files to sell 5M shares of common stock »

JMP Securities is acting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TXN

Texas Instruments

$120.00

0.56 (0.47%)

16:26
01/23/18
01/23
16:26
01/23/18
16:26
Technical Analysis
Technical Take: Texas Instruments drops sharply after results »

The shares were last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

COF

Capital One

$105.71

0.22 (0.21%)

16:26
01/23/18
01/23
16:26
01/23/18
16:26
Hot Stocks
Breaking Hot Stocks news story on Capital One »

Capital One reports Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

JAX

J. Alexander's

$10.20

-0.3 (-2.86%)

16:26
01/23/18
01/23
16:26
01/23/18
16:26
Hot Stocks
J. Alexander's major holders support 99 Restaurants acquisition »

Substantial holders of J.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

TK

Teekay Corp.

$10.74

0.05 (0.47%)

16:25
01/23/18
01/23
16:25
01/23/18
16:25
Syndicate
Teekay Corp. 10M share Spot Secondary; price range $9.75-$10.00 »

Morgan Stanley,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COF

Capital One

$105.71

0.22 (0.21%)

16:25
01/23/18
01/23
16:25
01/23/18
16:25
Hot Stocks
Breaking Hot Stocks news story on Capital One »

Capital One reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

ROL

Rollins

16:23
01/23/18
01/23
16:23
01/23/18
16:23
Hot Stocks
Rollins raises dividend 21.7% to 14c »

Rollins approved a 21.7%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

VLO

Valero

$98.69

-0.26 (-0.26%)

16:23
01/23/18
01/23
16:23
01/23/18
16:23
Hot Stocks
Valero announces additional $2.5B share repurchase authorization »

The board of Valero…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

CMRE

Costamare

$6.16

-0.12 (-1.91%)

16:23
01/23/18
01/23
16:23
01/23/18
16:23
Earnings
Costamare reports Q4 EPS 17c, consensus 15c »

On January 23, 2018,the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

COF

Capital One

$105.71

0.22 (0.21%)

16:22
01/23/18
01/23
16:22
01/23/18
16:22
Hot Stocks
Capital One reports Q4 net interest margin 7.03%, down 5 bps »

Reports Efficiency ratio…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

VLO

Valero

$98.69

-0.26 (-0.26%)

16:21
01/23/18
01/23
16:21
01/23/18
16:21
Hot Stocks
Valero increases dividend 14% »

The board of Valero…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

UMPQ

Umpqua Holdings

$22.11

-0.18 (-0.81%)

16:21
01/23/18
01/23
16:21
01/23/18
16:21
Earnings
Breaking Earnings news story on Umpqua Holdings »

Umpqua Holdings reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 13

    Mar

COF

Capital One

$105.71

0.22 (0.21%)

16:21
01/23/18
01/23
16:21
01/23/18
16:21
Earnings
Capital One reports Q4 adjusted EPS $1.62, consensus $1.88 »

Reports Q4 revenue $7B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

MULE

MuleSoft

$25.08

-0.31 (-1.22%)

16:20
01/23/18
01/23
16:20
01/23/18
16:20
Initiation
MuleSoft initiated  »

MuleSoft initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.